Joint Scientific Consultation (JSC) offers a critical opportunity for manufacturers to receive early feedback on their EU Joint Clinical Assessment (JCA) strategy, but with only a limited number of products selected each year, many companies are uncertain about what the process truly involves and how best to prepare.
In this webinar, we explored practical insights into the realities of preparing for and conducting a JSC, based on our first-hand experience. In conversation with Patrick Hopkinson, we discussed alternative routes of advice for manufacturers who are not selected for, or are not seeking, a JSC.
Designed for professionals navigating the EU JCA landscape, this session addressed whether, when and how to pursue a JSC, and what strategic alternatives may be available.
Date of recording: 12th June 2026
If you have questions about the webinar or want to explore how these insights apply to your organisation, please Get in Touch with our team today.
With over a decade of experience delivering HTA submissions, value materials and evidence generation activities fully in-house, our talented Value & Access team are ready to support you with your EU JCA and JSC activities.
